SEC Form 3
FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 04/30/2016 | 3. Issuer Name and Ticker or Trading Symbol TETRALOGIC PHARMACEUTICALS CORP [ TLOG ] | |||||||||||||
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 7,000 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Option (Right to Purchase) | (1) | 02/24/2024 | Common Stock | 25,000 | 7.72 | D | |
Stock Option (Right to Purchase) | (2) | 03/18/2025 | Common Stock | 11,500 | 4.51 | D |
Explanation of Responses: |
1. 13,530 option shares are currently exercisable. The option shares vest and become exercisable over a four-year period that commenced on February 24, 2014. Twenty-five percent (25%) of the option shares vested and became exercisable on February 24, 2015. The remainder vest monthly, beginning on March 24, 2015, at a rate of 520 shares per month for thirty-five (35) months following March 24,2015 and a rate of 550 shares in the thirty-sixth month. |
2. 3,120 option shares are currently exercisable. The option shares vest and become exercisable over a four-year period that commenced on April 18, 2015. The option shares vest monthly at a rate of 240 shares per month for forty-seven (47) months following April 18, 2015 and a rate of 220 shares in the forty-eighth month. |
Remarks: |
/s/ Richard Sherman, Attorney-In-Fact for Patrick Hutchison | 05/09/2016 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |